SYNH Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 Sep 2023 @ 16:00):

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America...

Stats
Today's Volume	6.70M
Average Volume	1.32M
Market Cap	4.46B
EPS	$0 ( 2024-02-14 )
Next earnings date	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	61.40
ATR14	$0.108 (0.25%)

Insider Trading

Date	Person	Action	Amount	type
2023-09-28	Zulueta Alfonso G	Sell	3 493	Class A Common Stock
2023-09-28	Zulueta Alfonso G	Sell	4 863	Class A Common Stock
2023-09-28	Wilkes David S.	Sell	4 973	Class A Common Stock
2023-09-28	Wilkes David S.	Sell	4 863	Class A Common Stock
2023-09-28	Monaghan Matthew E.	Sell	19 777	Class A Common Stock

INSIDER POWER
-46.04
Last 97 transactions
Buy: 420 799 \| Sell: 674 760

Volume Correlation

Long: -0.27 (neutral)

Short: 0.28 (neutral)

Signal:(72.61) Neutral

Syneos Health Inc Correlation

10 Most Positive Correlations
ISNS	0.919
GAINL	0.894
APOP	0.85
TDAC	0.844
SVOK	0.841
RMRM	0.828
PAIC	0.825
YMAB	0.822
HBNC	0.812

10 Most Negative Correlations
BOCH	-0.943
SHSP	-0.903
MMAC	-0.836
NUVL	-0.836
QADA	-0.818
MCBC	-0.804
NETE	-0.804
TESS	-0.804

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Syneos Health Inc Correlation - Currency/Commodity

0.67
( moderate )

0.66
( moderate )

0.00
( neutral )

0.28
( neutral )

0.46
( neutral )

-0.58
( weak negative )

Syneos Health Inc Financials

Annual	2022
Revenue:	$5.39B
Gross Profit:	$1.25B (23.26 %)
EPS:	$2.57

Q2	2023
Revenue:	$1.37B
Gross Profit:	$294.72M (21.57 %)
EPS:	$0.0100

Q1	2023
Revenue:	$1.36B
Gross Profit:	$268.25M (19.77 %)
EPS:	$-0.700

Q4	2022
Revenue:	$1.36B
Gross Profit:	$318.16M (23.40 %)
EPS:	$0.540

Financial Reports:

No articles found.

Syneos Health Inc

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.